NCT00410514

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled, Multi-center Study to Evaluate the Urodynamics and Safety of YM178 in Male Subjects With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 200 (actual)
• Sponsor: Astellas Pharma Inc · Industry
• Sex: Male
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.

Conditions

• Lower Urinary Tract Symptoms
• Bladder Outlet Obstruction

Interventions

Type	Name	Description
DRUG	Mirabegron	oral
DRUG	Placebo	oral

Timeline

• Start date: 2006-12-01
• Primary completion: 2008-08-01
• Completion: 2008-08-01
• First posted: 2006-12-13
• Last updated: 2014-04-04
• Results posted: 2012-09-05

Locations

27 sites across 2 countries: United States, Canada